Literature DB >> 10467235

Altered arterial concentrations of placental hormones during maximal placental growth in a model of placental insufficiency.

T R Regnault1, R J Orbus, F C Battaglia, R B Wilkening, R V Anthony.   

Abstract

Pregnant ewes were exposed chronically to thermoneutral (TN; 20+/-2 degrees C, 30% relative humidity; n=8) or hyperthermic (HT; 40+/-2 degrees C 12 h/day, 35+/-2 degrees C 12 h/day, 30% relative humidity, n=6) environments between days 37 and 93 of pregnancy. Ewes were killed following 56 days of exposure to either environment (days in treatment (dit)), corresponding to 93+/-1 day post coitus (dpc). Maternal core body temperatures (CBT) in HT ewes were significantly elevated above the TN ewes (HT; 39.86+/-0.1 degrees C vs TN; 39.20+/-0.1 degrees C; P<0.001). Both groups of animals displayed circadian CBT, though HT ewes had elevated amplitudes (HT; 0.181+/-0.002 degrees C vs TN; 0.091+/-0.002 degrees C; P<0.001) and increased phase shift constants (HT; 2100 h vs TN; 1800 h; P<0.001). Ewes exposed to chronic heat stress had significantly reduced progesterone and ovine placental lactogen (oPL) concentrations from 72 and 62 dpc respectively (P<0.05), corresponding to approximately 30 dit. However, when compared with the TN ewes, HT cotyledonary tissue oPL mRNA and protein concentrations were not significantly different (P>0.1). Prolactin concentrations rose immediately upon entry into the HT environment, reaching concentrations approximately four times that of TN ewes, a level maintained throughout the study (HT; 216.31+/-32.82 vs TN; 54. 40+/-10.0; P<0.0001). Despite similar feed intakes and euglycemia in both groups of ewes, HT fetal body weights were significantly reduced when compared with TN fetuses (HT; 514.6+/-48.7 vs TN; 703. 4+/-44.8; P<0.05), while placental weights (HT; 363.6+/-63.3 vs TN; 571.2+/-95.9) were not significantly affected by 56 days of heat exposure. Furthermore, the relationship between body weight and fetal length, the ponderal index, was significantly reduced in HT fetuses (HT; 3.01+/-0.13 vs TN; 3.57+/-0.18; P<0.05). HT fetal liver weights were also significantly reduced (HT; 27.31+/-4.73 vs TN; 45.16+/-6.16; P<0.05) and as a result, the brain/liver weight ratio was increased. This study demonstrates that chronic heat exposure lowers circulating placental hormone concentrations. The observation that PL mRNA and protein contents are similar across the two treatments, suggests that reduced hormone concentrations are the result of impaired trophoblast cell development, specifically trophoblast migration. Furthermore, the impact of heat exposure during maximal placental growth is great enough to restrict early fetal development, even before the fetal maximal growth phase (100 dpc-term). These data highlight that intrauterine growth retardation (IUGR) may result primarily from placental trophoblast cell dysfunction, and secondarily from later reduced placental size.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10467235     DOI: 10.1677/joe.0.1620433

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  22 in total

1.  β2-Adrenergic receptor desensitization in perirenal adipose tissue in fetuses and lambs with placental insufficiency-induced intrauterine growth restriction.

Authors:  Xiaochuan Chen; Anna L Fahy; Alice S Green; Miranda J Anderson; Robert P Rhoads; Sean W Limesand
Journal:  J Physiol       Date:  2010-07-19       Impact factor: 5.182

2.  eNOS, NO, and the activation of ERK and AKT signaling at mid-gestation and near-term in an ovine model of intrauterine growth restriction.

Authors:  Juan A Arroyo; Russell V Anthony; Thomas A Parker; Henry L Galan
Journal:  Syst Biol Reprod Med       Date:  2010-02       Impact factor: 3.061

3.  Early developmental influences on hepatic organogenesis.

Authors:  Melanie A Hyatt; Helen Budge; Michael E Symonds
Journal:  Organogenesis       Date:  2008-07       Impact factor: 2.500

4.  Elevated plasma norepinephrine inhibits insulin secretion, but adrenergic blockade reveals enhanced β-cell responsiveness in an ovine model of placental insufficiency at 0.7 of gestation.

Authors:  A R Macko; D T Yates; X Chen; A S Green; A C Kelly; L D Brown; S W Limesand
Journal:  J Dev Orig Health Dis       Date:  2013-10       Impact factor: 2.401

5.  Intrauterine growth restriction decreases NF-κB signaling in fetal pulmonary artery endothelial cells of fetal sheep.

Authors:  R Blair Dodson; Kyle N Powers; Jason Gien; Paul J Rozance; Gregory Seedorf; David Astling; Kenneth Jones; Timothy M Crombleholme; Steven H Abman; Cristina M Alvira
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-05-03       Impact factor: 5.464

Review 6.  Investigating the causes of low birth weight in contrasting ovine paradigms.

Authors:  J M Wallace; T R H Regnault; S W Limesand; W W Hay; R V Anthony
Journal:  J Physiol       Date:  2005-03-17       Impact factor: 5.182

7.  Increased fetal myocardial sensitivity to insulin-stimulated glucose metabolism during ovine fetal growth restriction.

Authors:  James S Barry; Paul J Rozance; Laura D Brown; Russell V Anthony; Kent L Thornburg; William W Hay
Journal:  Exp Biol Med (Maywood)       Date:  2016-02-11

8.  Decreased placental X-linked inhibitor of apoptosis protein in an ovine model of intrauterine growth restriction.

Authors:  Juan A Arroyo; Russell V Anthony; Henry L Galan
Journal:  Am J Obstet Gynecol       Date:  2008-03-04       Impact factor: 8.661

9.  Specificity protein-1 and -3 trans-activate the ovine placental lactogen gene promoter.

Authors:  K M Jeckel; S W Limesand; R V Anthony
Journal:  Mol Cell Endocrinol       Date:  2009-04-21       Impact factor: 4.102

10.  The relationship between transplacental O2 diffusion and placental expression of PlGF, VEGF and their receptors in a placental insufficiency model of fetal growth restriction.

Authors:  Timothy R H Regnault; Barbra de Vrijer; Henry L Galan; Meredith L Davidsen; Karen A Trembler; Frederick C Battaglia; Randall B Wilkening; Russell V Anthony
Journal:  J Physiol       Date:  2003-05-09       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.